Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders EJ Baxter, LM Scott, PJ Campbell, C East, N Fourouclas, S Swanton, ... The Lancet 365 (9464), 1054-1061, 2005 | 4645 | 2005 |
JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis LM Scott, W Tong, RL Levine, MA Scott, PA Beer, MR Stratton, PA Futreal, ... New England Journal of Medicine 356 (5), 459-468, 2007 | 1737 | 2007 |
Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study PJ Campbell, LM Scott, G Buck, K Wheatley, CL East, JT Marsden, A Duffy, ... The Lancet 366 (9501), 1945-1953, 2005 | 896 | 2005 |
MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort PA Beer, PJ Campbell, LM Scott, AJ Bench, WN Erber, D Bareford, ... Blood, The Journal of the American Society of Hematology 112 (1), 141-149, 2008 | 576 | 2008 |
A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells LM Scott, CI Civin, P Rorth, AD Friedman | 516 | 1992 |
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome D Bercovich, I Ganmore, LM Scott, G Wainreb, Y Birger, A Elimelech, ... The Lancet 372 (9648), 1484-1492, 2008 | 398 | 2008 |
PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2β/CBFβ proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature … I Nuchprayoon, S Meyers, LM Scott, J Suzow, S Hiebert, AD Friedman Molecular and cellular biology 14 (8), 5558-5568, 1994 | 392 | 1994 |
Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia LM Scott, MA Scott, PJ Campbell, AR Green Blood 108 (7), 2435-2437, 2006 | 388 | 2006 |
Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation PJ Campbell, EJ Baxter, PA Beer, LM Scott, AJ Bench, BJP Huntly, ... Blood 108 (10), 3548-3555, 2006 | 375 | 2006 |
Deletion of α4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing LM Scott, GV Priestley, T Papayannopoulou Molecular and cellular biology 23 (24), 9349-9360, 2003 | 365 | 2003 |
Molecular pathways in bone marrow homing: dominant role of α4β1 over β2-integrins and selectins T Papayannopoulou, GV Priestley, B Nakamoto, V Zafiropoulos, LM Scott Blood, The Journal of the American Society of Hematology 98 (8), 2403-2411, 2001 | 247 | 2001 |
JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F–positive essential thrombocythemia J Li, D Spensberger, JS Ahn, S Anand, PA Beer, C Ghevaert, E Chen, ... Blood, The Journal of the American Society of Hematology 116 (9), 1528-1538, 2010 | 241 | 2010 |
The JAK2 exon 12 mutations: A comprehensive review LM Scott American journal of hematology 86 (8), 668-676, 2011 | 220 | 2011 |
The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders LM Scott, PJ Campbell, EJ Baxter, T Todd, P Stephens, S Edkins, ... Blood 106 (8), 2920-2921, 2005 | 209 | 2005 |
VCAM-1 expression in adult hematopoietic and nonhematopoietic cells is controlled by tissue-inductive signals and reflects their developmental origin T Ulyanova, LM Scott, GV Priestley, Y Jiang, B Nakamoto, PA Koni, ... Blood 106 (1), 86-94, 2005 | 196 | 2005 |
The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms AV Jones, PJ Campbell, PA Beer, S Schnittger, AM Vannucchi, K Zoi, ... Blood, The Journal of the American Society of Hematology 115 (22), 4517-4523, 2010 | 126 | 2010 |
The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels MJ Percy, LM Scott, WN Erber, CN Harrison, JT Reilly, FGC Jones, ... haematologica 92 (12), 1607-1614, 2007 | 113 | 2007 |
Lack of α4 integrin expression in stem cells restricts competitive function and self-renewal activity GV Priestley, LM Scott, T Ulyanova, T Papayannopoulou Blood 107 (7), 2959-2967, 2006 | 108 | 2006 |
Inhibition of the Bcl-xL deamidation pathway in myeloproliferative disorders R Zhao, GA Follows, PA Beer, LM Scott, BJP Huntly, AR Green, ... New England Journal of Medicine 359 (26), 2778-2789, 2008 | 106 | 2008 |
Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia vera LM Scott, PA Beer, AJ Bench, WN Erber, AR Green British journal of haematology 139 (3), 511-512, 2007 | 92 | 2007 |